Christopher Bunka - 07 May 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Signature
/Chris Bunka/
Issuer symbol
LEXX
Transactions as of
07 May 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 12:48:45 UTC
Next filing
09 Jun 2021

Quoteable Key Fact

"Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 09 Jun 2021."

Quick Takeaways

  • This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
  • 1 reported transaction and 4 derivative rows are listed below.
  • Filing timestamp: 09 Jun 2021, 12:48.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 215,912 07 May 2021 Private Holding Company
holding LEXX common shares 273,543 07 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Other $0 -23,334 -42% $0.000000 32,667 07 May 2021 Common Shares 23,334 $10.20 Direct F1
holding LEXX Warrants 6,667 07 May 2021 Common Shares 6,667 $10.50 Private Holding Company
holding LEXX Stock Options 30,001 07 May 2021 Common Shares 23,334 $10.20 Direct
holding LEXX Stock Options 56,001 07 May 2021 Common Shares 26,000 $5.83 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cancelled Options
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .